Nifty
Sensex
:
:
22402.40
73852.94
34.40 (0.15%)
114.49 (0.16%)

Hospital & Healthcare Services

Rating :
39/99

BSE: 543328 | NSE: KRSNAA

562.40
24-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  567.95
  •  578.95
  •  559.00
  •  567.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  105596
  •  599.79
  •  767.90
  •  448.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,834.38
  • 32.16
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,701.77
  • 0.48%
  • 2.39

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.03%
  • 21.65%
  • 27.73%
  • FII
  • DII
  • Others
  • 3.34%
  • 15.14%
  • 5.11%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 25.87
  • 5.39

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 15.76
  • 5.78

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 38.48
  • -29.97

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
158.32
118.10
34.06%
155.45
122.94
26.44%
139.58
112.86
23.68%
133.23
108.25
23.08%
Expenses
120.93
88.69
36.35%
123.66
92.32
33.95%
108.21
85.07
27.20%
98.74
80.22
23.09%
EBITDA
37.39
29.41
27.13%
31.79
30.62
3.82%
31.36
27.79
12.85%
34.48
28.03
23.01%
EBIDTM
23.62%
24.90%
20.45%
24.91%
22.47%
24.62%
25.88%
25.89%
Other Income
4.08
4.54
-10.13%
4.16
4.27
-2.58%
4.22
4.64
-9.05%
5.93
4.10
44.63%
Interest
4.15
2.26
83.63%
3.06
1.81
69.06%
1.96
1.39
41.01%
2.24
1.80
24.44%
Depreciation
21.23
13.91
52.62%
19.46
12.92
50.62%
15.73
12.36
27.27%
14.60
10.45
39.71%
PBT
16.09
17.78
-9.51%
13.42
20.16
-33.43%
17.89
18.68
-4.23%
23.58
19.89
18.55%
Tax
3.12
4.14
-24.64%
2.92
4.83
-39.54%
3.25
4.46
-27.13%
4.66
1.95
138.97%
PAT
12.97
13.64
-4.91%
10.50
15.34
-31.55%
14.64
14.21
3.03%
18.92
17.94
5.46%
PATM
8.19%
11.55%
6.75%
12.47%
10.49%
12.60%
14.20%
16.57%
EPS
4.02
4.34
-7.37%
3.34
4.88
-31.56%
4.66
4.53
2.87%
6.03
5.71
5.60%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Net Sales
586.58
487.12
455.45
Net Sales Growth
26.92%
6.95%
 
Cost Of Goods Sold
123.74
74.18
60.30
Gross Profit
462.84
412.94
395.15
GP Margin
78.90%
84.77%
86.76%
Total Expenditure
451.54
364.82
323.97
Power & Fuel Cost
-
9.08
6.34
% Of Sales
-
1.86%
1.39%
Employee Cost
-
74.56
54.15
% Of Sales
-
15.31%
11.89%
Manufacturing Exp.
-
99.16
128.38
% Of Sales
-
20.36%
28.19%
General & Admin Exp.
-
105.63
72.08
% Of Sales
-
21.68%
15.83%
Selling & Distn. Exp.
-
0.00
0.00
% Of Sales
-
0%
0%
Miscellaneous Exp.
-
2.21
2.73
% Of Sales
-
0.45%
0.60%
EBITDA
135.02
122.30
131.48
EBITDA Margin
23.02%
25.11%
28.87%
Other Income
18.39
19.38
14.91
Interest
11.41
7.70
18.49
Depreciation
71.02
53.78
41.39
PBT
70.98
80.20
86.51
Tax
13.95
18.09
18.12
Tax Rate
19.65%
22.56%
20.95%
PAT
57.03
62.11
68.39
PAT before Minority Interest
57.03
62.11
68.39
Minority Interest
0.00
0.00
0.00
PAT Margin
9.72%
12.75%
15.02%
PAT Growth
-6.71%
-9.18%
 
EPS
17.66
19.23
21.17

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Shareholder's Funds
738.74
684.41
Share Capital
15.70
15.70
Total Reserves
720.37
666.67
Non-Current Liabilities
70.58
69.94
Secured Loans
24.28
33.07
Unsecured Loans
0.00
0.00
Long Term Provisions
1.23
0.32
Current Liabilities
99.19
121.02
Trade Payables
62.13
77.30
Other Current Liabilities
34.92
41.74
Short Term Borrowings
0.00
0.00
Short Term Provisions
2.15
1.98
Total Liabilities
908.51
875.37
Net Block
470.68
385.69
Gross Block
626.62
491.35
Accumulated Depreciation
155.94
105.66
Non Current Assets
682.74
541.22
Capital Work in Progress
25.48
28.26
Non Current Investment
0.29
0.29
Long Term Loans & Adv.
26.39
17.87
Other Non Current Assets
159.91
109.11
Current Assets
225.76
334.15
Current Investments
0.00
0.00
Inventories
25.07
9.17
Sundry Debtors
73.10
57.87
Cash & Bank
108.80
241.88
Other Current Assets
18.79
8.17
Short Term Loans & Adv.
5.85
17.05
Net Current Assets
126.57
213.13
Total Assets
908.50
875.37

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Cash From Operating Activity
76.30
128.42
PBT
80.20
86.51
Adjustment
44.81
49.20
Changes in Working Capital
-35.58
-0.66
Cash after chg. in Working capital
89.43
135.05
Interest Paid
0.00
0.00
Tax Paid
-13.13
-6.63
Other Direct Exp. Paid
0.00
0.00
Extra & Other Items
0.00
0.00
Cash From Investing Activity
-108.89
-240.64
Net Fixed Assets
-132.49
Net Investments
0.00
Others
23.60
Cash from Financing Activity
-33.15
175.99
Net Cash Inflow / Outflow
-65.73
63.78
Opening Cash & Equivalents
88.45
24.68
Closing Cash & Equivalent
22.72
88.45

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Book Value (Rs.)
234.43
217.33
ROA
6.96%
7.81%
ROE
8.76%
10.02%
ROCE
11.75%
14.47%
Fixed Asset Turnover
0.87
0.93
Receivable days
49.07
46.38
Inventory Days
12.83
7.35
Payable days
343.02
467.93
Cash Conversion Cycle
-281.13
-414.20
Total Debt/Equity
0.04
0.06
Interest Cover
11.42
5.68

News Update:


  • Krsnaa Diagnostics incorporates wholly owned subsidiary
    9th Apr 2024, 15:26 PM

    The company has incorporated wholly owned subsidiary to carry out business in the field of Diagnostic Services

    Read More
  • Krsnaa Diagnostics gets nod to incorporate wholly owned subsidiary
    13th Feb 2024, 09:48 AM

    The Board of Directors at their meeting held on February 12, 2024, have approved the same

    Read More
  • Krsnaa Diagnostics - Quarterly Results
    12th Feb 2024, 22:01 PM

    Read More
  • Krsnaa Diagnostics bags contract to provide MRI, CT Scan Services in Maharashtra
    30th Jan 2024, 11:28 AM

    The Company is in the process of entering into an agreement with the authority in this behalf

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.